The Hindu Business Line : Dr Reddy’s to set up facility for opium-based drugs at Vizag

Hyderabad, Aug. 2 Pharma major Dr Reddy’s Laboratories Ltd will set up an exclusive manufacturing facility for opium-based drugs with an investment of over Rs 40 crore.

“The plant will come up at Visakhapatnam. We are also considering commencing production of finished dosages in opium-based drugs,” Mr G.V. Prasad, Vice-Chairman and Chief Executive Officer, told Business Line here.

Dr Reddy’s, one of the only two companies in India (the other being Opium and Alkaloid Works) which has licence for manufacturing opium-based drugs (like morphine), is of the opinion that the segment can yield significant revenue over a period of time. “The competition here is limited and we wish to generate a steady stream of revenue from this division,” Mr Prasad said.

In the next four years, Dr Reddy’s is expecting a “significant revenue from the opium-based drugs”, he added.

JOINT VENTURE

This would be possible as the proposed joint venture of Dr Reddy’s with the UK-based Johnson Matthey, world’s largest producer of opium-based drugs, is expected to be operational over the next one year. “We are currently working on the financial aspects of the joint venture, Macred India. The final projects costs are being worked out,” Mr Prasad said.

The Foreign Investment Promotion Board (FIPB) recently accorded approval to Matthey’s plan to acquire 49 per cent stake in Macred India. There would be good prospects for Macred India as the combined strengths of Dr Reddy’s and Matthey can tap the global market in the segment, he added.

More Stories on : New Projects | Pharmaceuticals | Dr. Reddy's Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Dr Reddy’s to set up facility for opium-based drugs at Vizag

GSPC bids for three oil and gas blocks in Egypt

USFDA nod for Aurobindo's injections

BMW India ties up with ORIX Auto

L&T to complete recast of strategic biz units soon

Suzlon gets shareholders’ nod to raise Rs 5,000 cr thru securities

RINL achieves record turnover

India Inc has lower profit cushion to service debt